Exploring a four-gene risk model based on doxorubicin resistance-associated lncRNAs in hepatocellular carcinoma
Article in Frontiers in Pharmacology (November 2022)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (November 2022)
Article in Molecular Medicine (August 2022)
Article in Nature Communications (March 2022)